PSNC Briefing 014/22: HRT Serious Shortage Protocols (SSPs) FAQs

Published on: 4th May 2022 | Updated on: 30th June 2022

In response to a significant ongoing disruption affecting three Hormone Replacement Therapy (HRT) medicines, the Department of Health and Social Care (DHSC) have issued three new Serious Shortage Protocols (SSPs).

PSNC’s briefing titled ‘HRT Serious Shortage Protocols (SSPs) FAQs‘ provides answers to commonly asked FAQs around the new SSPs issued on 29 April 2022 for the three HRT medicines:

HRT medicine SSP number Expiry date*
Oestrogel® Pump-Pack 0.06% gel SSP019 29 July 2022
Ovestin® 1mg cream SSP020 29 July 2022
Premique® Low Dose 0.3mg/1.5mg modified-release tablets SSP021 29 July 2022


For more information on this topic please email